Images
![Rivastigmine transdermal (Rivastigmine transdermal [ riv-a-stig-meen ])-CL7 1.5 mg-1.5 mg-Yellow-Capsule-shape](https://cdn.themeditary.com/vimedia/h200/2023/09/06/rivastigmine-transdermal-rivastigmine-transdermal-riv-a-stig-meen-cl7-1-5-mg-1-5-mg-yellow-capsule-s-1694014805.webp "CL7 1.5 mg Pill - yellow capsule-shape")
![Rivastigmine transdermal (Rivastigmine transdermal [ riv-a-stig-meen ])-CL7 1.5 mg-1.5 mg-Yellow-Capsule-shape](https://cdn.themeditary.com/vimedia/h200/2023/09/06/rivastigmine-transdermal-rivastigmine-transdermal-riv-a-stig-meen-cl7-1-5-mg-1-5-mg-yellow-capsule-s-1694014806.webp "CL7 1.5 mg Pill - yellow capsule-shape")
Rivastigmine transdermal |
|
| Generic Name: | rivastigmine transdermal [ riv-a-stig-meen ] |
| Imprint: | CL7 1.5 mg |
| Strength: | 1.5 mg |
| Color: | Yellow |
| Size: | N/A |
| Shape: | Capsule-shape |
| Availability: | Prescription only |
| Drug Class: | Cholinesterase inhibitors |
| Pregnancy Category: | B - No proven risk in humans |
| CSA Schedule: | Not a controlled drug |
| Labeler / Supplier: | N/A |
| National Drug Code (NDC): | 33342-0089 |
| Inactive Ingredients: | Magnesium stearate, Microcrystalline cellulose, Silicon dioxide, Gelatin, Titanium dioxide, Sodium lauryl sulfate, Ferric oxide red, Ferric oxide yellow, Hypromelloses, |
